Filing Flows › Profound Medical (PROF) › Q1 2025
Profound Medical (PROF) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 8, 2025
Profound Medical (PROF) reported revenue of $2.6M for the first quarter 2025 (Q1 2025), +82% from a year earlier and -37% from the quarter before. Operating margin was -426.0%, net loss $10.7M (409.2% of revenue).
Profound Medical, Q1 2025: revenue $2.6M (+82% year over year), operating margin -426.0%, net loss $10.7M, operating cash flow −$8.3M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.6M | -37% | +82% |
| Operating profit | −$11.2M | — | — |
| Net earnings | −$10.7M | — | — |
| Operating cash flow | −$8.3M | — | — |
What changed
Revenue was $2.6M in Q1 2025, up 82% year over year and down 37% from the previous quarter. Recurring - non-capital was the largest line at 69% of revenue. Recurring - non-capital added $362K year over year (up 25%), 31% of the total change.
Gross margin was 70.7%, up 10.5 points from a year earlier. Operating costs exceeded revenue by $11.2M, an operating margin of -426.0%. Operating expenses grew 49% against revenue growth of 82%. The fastest-growing cost line was SG&A (+71%). The quarter ended with a net loss of $10.7M, wider than the previous quarter's $4.9M loss.
Operating cash flow was −$8.3M. Non-cash charges added back $163K of depreciation and amortization and $1.0M of share-based compensation. Working capital and other items added $1.3M.
Questions
What was Profound Medical's revenue in the first quarter 2025?
Profound Medical (PROF) reported revenue of $2.6M for the first quarter 2025 (Q1 2025), +82% from a year earlier and -37% from the quarter before.
Was Profound Medical profitable in the first quarter 2025?
Operating loss was $11.2M (-426.0% of revenue) and net loss $10.7M.
Source: Profound Medical 10-Q on SEC EDGAR.